Patient-reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in NCCTG (Alliance) N1031 (Randomized Phase II Study of Two Doses of Pixantrone in Patients with Metastatic Breast Cancer)
- Citation:
- Quality of Life Research vol 22 (1 Supplement) 81-82 (abstr 1086)
- Meeting Instance:
- ISOQOL 2013
- Year:
- 2013
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- Yes
- Biospecimen:
- No
- SDC:
- Yes
- Parents:
- None
- Children:
- None